Randomized trial evaluates OCR impacts on tumor detection in radiology, indicating vulnerabilities in AI models.
Purpose: Vision-language models (VLMs) are increasingly proposed for radiologic decision support, yet the security implications of deploying optical character recognition (OCR)-capable models in diagnostic workflows remain poorly characterized. When image-embedded text is not treated as untrusted input, the visual channel becomes vulnerable to adversarial manipulation. Approach: Ten VLMs, none validated for clinical diagnosis, were evaluated on 600 brain magnetic resonance imaging studies for binary tumor detection under 5 conditions: clean input, visible radiology report injection, human-imperceptible stealth OCR injection, and multi-stage immune-prompt defense. A total of 27,000 inference calls were analyzed. Results: At baseline, performance was heterogeneous, with a median accuracy of 0.69, a sensitivity of 0.79, and a specificity of 0.59. Visible injection caused universal specificity collapse to 0.00 across all models with a false-positive rate (FPR) of 1.00 and a median attack success rate (ASR) of 0.97. Stealth injection, despite being imperceptible to human reviewers, drove substantial degradation with a median accuracy of 0.43, an ASR of 0.57, and an FPR of 0.84. Immune prompting achieved only partial mitigation: under stealth injection, median ASR decreased to 0.44, and accuracy improved to 0.56, yet residual overcalling persisted with a median FPR of 0.67, and three models maintained an FPR of 1.00. Conclusions: Commercial VLMs exhibit a deployment-critical failure mode in radiology-like scenarios: OCR-readable text embedded in images can override pixel-level evidence, even under stealth conditions that evade human inspection. Prompt-level defenses provide insufficient protection. Any clinical integration of VLMs must be governed by system-level safeguards, including OCR-aware input handling, provenance controls, and enforced human verification, before deployment in safety-sensitive environments.
No takes yet. Share an insight, caveat, or question.
Oztürk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: